Arca Biopharma | ABIO - Beneficio Operativo

Precio De Mercado
44.52
Cambio Diario
4.62 11.58%
Mensual
29.72%
Anual
290.87%
Q1 Expectativa
37.74




Beneficio Operativo Cambio Fecha
Alterity Therapeutics Limited AUD -7.77M 2.99M 2023-06
Amgen USD 3.96B 464M 2025-12
Arca Biopharma USD -34.43M 326K 2025-12
Biogen USD 659.6M 192.2M 2025-09
Brainstorm Cell Therapeutics USD -2.05M 526K 2025-09
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Capricor Therapeutics USD -29.16M 2.87M 2025-12
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD 56.04M 63.93M 2025-12
CSL USD 2.64B 1.97B 2025-12
Cytokinetics USD -178.37M 11.61M 2025-12
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Grifols EUR 320.55M 91.01M 2025-12
Laboratory Of America USD 382M 15.3M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
Otsuka Holdings JPY 67.25B 101.57B 2025-12
Pfizer USD 4.65B 3.99B 2025-12
United Therapeutics USD -14.6M 403.9M 2025-12